Skip to Content

Levoxyl FDA Alerts

The FDA Alert(s) below may be specifically about Levoxyl or relate to a group or class of drugs which include Levoxyl (levothyroxine).

MedWatch Safety Alerts are distributed by the FDA and published by Following is a list of possible medication recalls, market withdrawals, alerts and warnings. For the latest FDA MedWatch alerts, go here.

Recent FDA Alert(s) for levothyroxine

Levoxyl (levothyroxine sodium)

Oct 4, 2004

Audience: Endocrinologists and other healthcare professionals

FDA and King Pharmaceuticals notified healthcare professionals of revisions to the PRECAUTIONS, ADVERSE REACTIONS and DOSAGE AND ADMINISTRATION sections of labeling, describing reports of choking, gagging, tablets stuck in throat and dysphagia while taking Levoxyl. These reports have predominately occurred when Levoxyl tablets were not taken with water. It is recommended that Levoxyl tablets be taken with a full glass of water.

[September 17, 2004 Letter - King Pharmaceuticals]
[May 2004 Label - King Pharmaceuticals]

More Levoxyl Resources